Masanobu Horie
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Masanobu Horie has a total of 45 co-authors. Here are the top co-authors by number of shared publications:
- Hideaki Fujita
Department of Stem Cell Biology, Research Institute for Radiation Biology and Medicine, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima 734-8553, Japan
4 shared publications - Akira Ito
Department of Chemical Systems Engineering, Graduate School of Engineering, Nagoya University
3 shared publications Eiji Nagamori
Department of Biomedical Engineering, Osaka Institute of Technology, Osaka, Japan
3 shared publications- Yoshinori Kawabe
Department of Chemical Engineering, Faculty of Engineering, Kyushu University, 744 Motooka, Nishi-ku, Fukuoka 819-0395, Japan
3 shared publications - Eiji Nagamori
Department of Biomedical Engineering, Osaka Institute of Technology, 5-16-1 Omiya, Asahi-ku, Osaka 535-8585, Japan
2 shared publications Hideaki Fujita
Department of Stem Cell Biology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan
2 shared publications
Latest Publications
- 7 March 2026
- Published by Elsevier in Journal of Bioscience and Bioengineering
- Vol. 141 (6) , 450-455
Fetal bovine serum concentration-dependent differentiation of multi-layered myoblasts
- 7 March 2026
- Published by Elsevier in Journal of Bioscience and Bioengineering
- Vol. 141 (6) , 450-455
Fetal bovine serum concentration-dependent differentiation of multi-layered myoblasts
- 31 January 2026
- Published by Springer Nature in Cytotechnology
- Vol. 78 (1) , 37
Characteristics of human induced pluripotent stem cells cultured on soft substrates
This study investigated the impact of culture surface rigidity on the proliferation and maintenance of undifferentiated human induced pluripotent stem cells (hiPSCs), which are crucial in regenerative medicine and stem cell-based organ therapy. Given the need for a substantial number of cells per patient, there is a pressing demand for methods that ensure homogeneous and efficient large-scale cultivation of hiPSCs. Mechanotransduction, the process by which cells, including hiPSCs, respond to mechanical stimuli, has gained significant attention. We evaluated the effects of varying culture surface rigidity, examining changes in morphology, gene expression, and differentiation tendencies. Soft gels were made by altering acrylamide gel polymerization on functionalized glass slides, which were then coated with laminin. Cell attachment rates were quantified 24 h after seeding which varied according to substrate rigidity. The apparent proliferation rate was highest at 5 kPa, suggesting that hiPSCs sense rigidity. We further confirmed that this mechanosensing occurred through activation of the Hippo signaling pathway. In conclusion, this study revealed that the adhesion and proliferation of hiPSCs are significantly influenced by culture surface rigidity, with 5 kPa identified as the optimal condition for proliferation. This understanding may help optimize cell culture conditions for future organ regeneration and therapeutic applications.
- 31 January 2026
- Published by Springer Nature in Cytotechnology
- Vol. 78 (1) , 37
Characteristics of human induced pluripotent stem cells cultured on soft substrates
This study investigated the impact of culture surface rigidity on the proliferation and maintenance of undifferentiated human induced pluripotent stem cells (hiPSCs), which are crucial in regenerative medicine and stem cell-based organ therapy. Given the need for a substantial number of cells per patient, there is a pressing demand for methods that ensure homogeneous and efficient large-scale cultivation of hiPSCs. Mechanotransduction, the process by which cells, including hiPSCs, respond to mechanical stimuli, has gained significant attention. We evaluated the effects of varying culture surface rigidity, examining changes in morphology, gene expression, and differentiation tendencies. Soft gels were made by altering acrylamide gel polymerization on functionalized glass slides, which were then coated with laminin. Cell attachment rates were quantified 24 h after seeding which varied according to substrate rigidity. The apparent proliferation rate was highest at 5 kPa, suggesting that hiPSCs sense rigidity. We further confirmed that this mechanosensing occurred through activation of the Hippo signaling pathway. In conclusion, this study revealed that the adhesion and proliferation of hiPSCs are significantly influenced by culture surface rigidity, with 5 kPa identified as the optimal condition for proliferation. This understanding may help optimize cell culture conditions for future organ regeneration and therapeutic applications.
- 10 April 2024
- Published by Elsevier in Journal of Bioscience and Bioengineering
- Vol. 137 (6) , 480-486
Bone morphogenetic protein signaling inhibitor improves differentiation and function of 3D muscle construct fabricated using C2C12
- 10 April 2024
- Published by Elsevier in Journal of Bioscience and Bioengineering
- Vol. 137 (6) , 480-486
Bone morphogenetic protein signaling inhibitor improves differentiation and function of 3D muscle construct fabricated using C2C12
- Open Access
- 6 July 2023
- Published by Wiley in Cancer Science
- Vol. 114 (9) , 3750-3758
Effective magnetic hyperthermia induced by mitochondria‐targeted nanoparticles modified with triphenylphosphonium‐containing phospholipid polymers
Magnetic hyperthermia (MHT) is a promising cancer treatment because tumor tissue can be specifically damaged by utilizing the heat generated by nano‐heaters such as magnetite nanoparticles (MNPs) under an alternating magnetic field. MNPs are taken up by cancer cells, enabling intracellular MHT. Subcellular localization of MNPs can affect the efficiency of intracellular MHT. In this study, we attempted to improve the therapeutic efficacy of MHT by using mitochondria‐targeting MNPs. Mitochondria‐targeting MNPs were prepared by the modification of carboxyl phospholipid polymers containing triphenylphosphonium (TPP) moieties that accumulate in mitochondria. The mitochondrial localization of polymer‐modified MNPs was supported by transmission electron microscopy observations of murine colon cancer CT26 cells treated with polymer‐modified MNPs. In vitro and in vivo MHT using polymer‐modified MNPs revealed that the therapeutic effects were enhanced by introducing TPP. Our results indicate the validity of mitochondria targeting in enhancing the therapeutic outcome of MHT. These findings will pave the way for developing a new strategy for the surface design of MNPs and therapeutic strategies for MHT.
- 6 July 2023
- Published by Wiley in Cancer Science
- Vol. 114 (9) , 3750-3758
Open AccessEffective magnetic hyperthermia induced by mitochondria‐targeted nanoparticles modified with triphenylphosphonium‐containing phospholipid polymers
Magnetic hyperthermia (MHT) is a promising cancer treatment because tumor tissue can be specifically damaged by utilizing the heat generated by nano‐heaters such as magnetite nanoparticles (MNPs) under an alternating magnetic field. MNPs are taken up by cancer cells, enabling intracellular MHT. Subcellular localization of MNPs can affect the efficiency of intracellular MHT. In this study, we attempted to improve the therapeutic efficacy of MHT by using mitochondria‐targeting MNPs. Mitochondria‐targeting MNPs were prepared by the modification of carboxyl phospholipid polymers containing triphenylphosphonium (TPP) moieties that accumulate in mitochondria. The mitochondrial localization of polymer‐modified MNPs was supported by transmission electron microscopy observations of murine colon cancer CT26 cells treated with polymer‐modified MNPs. In vitro and in vivo MHT using polymer‐modified MNPs revealed that the therapeutic effects were enhanced by introducing TPP. Our results indicate the validity of mitochondria targeting in enhancing the therapeutic outcome of MHT. These findings will pave the way for developing a new strategy for the surface design of MNPs and therapeutic strategies for MHT.
- Open Access
Progress of Endogenous and Exogenous Nanoparticles for Cancer Therapy and Diagnostics
The focus of this brief review is to describe the application of nanoparticles, including endogenous nanoparticles (e.g., extracellular vesicles, EVs, and virus capsids) and exogenous nanoparticles (e.g., organic and inorganic materials) in cancer therapy and diagnostics. In this review, we mainly focused on EVs, where a recent study demonstrated that EVs secreted from cancer cells are associated with malignant alterations in cancer. EVs are expected to be used for cancer diagnostics by analyzing their informative cargo. Exogenous nanoparticles are also used in cancer diagnostics as imaging probes because they can be easily functionalized. Nanoparticles are promising targets for drug delivery system (DDS) development and have recently been actively studied. In this review, we introduce nanoparticles as a powerful tool in the field of cancer therapy and diagnostics and discuss issues and future prospects.
Open AccessProgress of Endogenous and Exogenous Nanoparticles for Cancer Therapy and Diagnostics
The focus of this brief review is to describe the application of nanoparticles, including endogenous nanoparticles (e.g., extracellular vesicles, EVs, and virus capsids) and exogenous nanoparticles (e.g., organic and inorganic materials) in cancer therapy and diagnostics. In this review, we mainly focused on EVs, where a recent study demonstrated that EVs secreted from cancer cells are associated with malignant alterations in cancer. EVs are expected to be used for cancer diagnostics by analyzing their informative cargo. Exogenous nanoparticles are also used in cancer diagnostics as imaging probes because they can be easily functionalized. Nanoparticles are promising targets for drug delivery system (DDS) development and have recently been actively studied. In this review, we introduce nanoparticles as a powerful tool in the field of cancer therapy and diagnostics and discuss issues and future prospects.
- 2 April 2022
- Published by Elsevier in Journal of Bioscience and Bioengineering
- Vol. 133 (6) , 509-514
Recent advances in animal cell technologies for industrial and medical applications
- 2 April 2022
- Published by Elsevier in Journal of Bioscience and Bioengineering
- Vol. 133 (6) , 509-514
Recent advances in animal cell technologies for industrial and medical applications
- Open Access
Contractile Activity of Myotubes Derived from Human Induced Pluripotent Stem Cells: A Model of Duchenne Muscular Dystrophy
Duchenne muscular dystrophy (DMD) is a genetic disorder that results from deficiency of the dystrophin protein. In recent years, DMD pathological models have been created using induced pluripotent stem (iPS) cells derived from DMD patients. In addition, gene therapy using CRISPR-Cas9 technology to repair the dystrophin gene has been proposed as a new treatment method for DMD. However, it is not known whether the contractile function of myotubes derived from gene-repaired iPS cells can be restored. We therefore investigated the maturation of myotubes in electrical pulse stimulation culture and examined the effect of gene repair by observing the contractile behaviour of myotubes. The contraction activity of myotubes derived from dystrophin-gene repaired iPS cells was improved by electrical pulse stimulation culture. The iPS cell method used in this study for evaluating muscle contractile activity is a useful technique for analysing the mechanism of hereditary muscular disease pathogenesis and for evaluating the efficacy of new drugs and gene therapy.
Open AccessContractile Activity of Myotubes Derived from Human Induced Pluripotent Stem Cells: A Model of Duchenne Muscular Dystrophy
Duchenne muscular dystrophy (DMD) is a genetic disorder that results from deficiency of the dystrophin protein. In recent years, DMD pathological models have been created using induced pluripotent stem (iPS) cells derived from DMD patients. In addition, gene therapy using CRISPR-Cas9 technology to repair the dystrophin gene has been proposed as a new treatment method for DMD. However, it is not known whether the contractile function of myotubes derived from gene-repaired iPS cells can be restored. We therefore investigated the maturation of myotubes in electrical pulse stimulation culture and examined the effect of gene repair by observing the contractile behaviour of myotubes. The contraction activity of myotubes derived from dystrophin-gene repaired iPS cells was improved by electrical pulse stimulation culture. The iPS cell method used in this study for evaluating muscle contractile activity is a useful technique for analysing the mechanism of hereditary muscular disease pathogenesis and for evaluating the efficacy of new drugs and gene therapy.
- 1 July 2020
- Published by Elsevier in Journal of Bioscience and Bioengineering
- Vol. 130 (1) , 98-105
Effect of cell-extracellular matrix interaction on myogenic characteristics and artificial skeletal muscle tissue
- 1 July 2020
- Published by Elsevier in Journal of Bioscience and Bioengineering
- Vol. 130 (1) , 98-105
Effect of cell-extracellular matrix interaction on myogenic characteristics and artificial skeletal muscle tissue
- 26 January 2017
- Published by Springer Nature
- p. 363-383
Magnetic Nanoparticles: Functionalization and Manufacturing of Pluripotent Stem Cells
- 26 January 2017
- Published by Springer Nature
- p. 363-383
Magnetic Nanoparticles: Functionalization and Manufacturing of Pluripotent Stem Cells
- Open Access
- 1 January 2015
- Published by Japanese Society for Dialysis Therapy in Nihon Toseki Igakkai Zasshi
- Vol. 48 (7) , 437-441
A case of difficult hemodialysis induction in a patient with acute intermittent porphyria
- 1 January 2015
- Published by Japanese Society for Dialysis Therapy in Nihon Toseki Igakkai Zasshi
- Vol. 48 (7) , 437-441
Open AccessA case of difficult hemodialysis induction in a patient with acute intermittent porphyria